HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) CME: Take the course for this article: Volume 60, Number 7, April 08, 2003 Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cakmak, S. Articles by Trouillas, P. Search for Related Content PubMed PubMed Citation Articles by Cakmak, S. Articles by Trouillas, P. Related Collections All Cerebrovascular disease/Stroke Cerebral venous thrombosis Stroke in young adults Risk factors in epidemiology

Cerebral venous thrombosis

Clinical outcome and systematic screening of prothrombotic factors

From the Service d’Urgences Neurovasculaires (Drs. Cakmak, Derex, Nighoghossian, Philippeau, and Trouillas) and Service de Neuroradiologie (Drs. Hermier and Froment), Hôpital Neurologique, Lyon; Laboratoire Central d’Hématologie et de Cytogénétique (Dr. Berruyer), Hôpital Louis Pradel, Bron; and Service de Biostatistique et d’Informatique Médicale (Dr. Adeleine), Lyon, France.

Address correspondence and reprint requests to Dr. Laurent Derex, Service d’Urgences Neurovasculaires, Hôpital Neurologique, 59, boulevard Pinel, 69003 Lyon, France; e-mail: lderex{at}yahoo.com

The authors studied 16 consecutive cases of cerebral venous thrombosis (CVT). Clinical outcome was good or excellent in 14 patients. Comprehensive hypercoagulable screening was done at least 3 months after the onset of CVT, including evaluation of genetic coagulation disorders and plasma levels of homocysteine and factor VIII. This screening was positive in 12 patients (75%). An acquired prothrombotic factor was identified in 9 of these 12 patients. Elevation of factor VIII plasma level was the most common coagulation disorder (8 patients).

This article has been cited by other articles:

				J. M. Ferro, P. Canhao, M.-G. Bousser, J. Stam, F. Barinagarrementeria, and for the ISCVT Investigators Early Seizures in Cerebral Vein and Dural Sinus Thrombosis: Risk Factors and Role of Antiepileptics Stroke, April 1, 2008; 39(4): 1152 - 1158. [Abstract] [Full Text] [PDF]

				C A Davie and P O'Brien Stroke and pregnancy J. Neurol. Neurosurg. Psychiatry, March 1, 2008; 79(3): 240 - 245. [Abstract] [Full Text] [PDF]

				E. M. Wysokinska, W. E. Wysokinski, R. D. Brown, K. Karnicki, I. Gosk-Beirska, D. Grill, and R. D. McBane II Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis Neurology, February 19, 2008; 70(8): 627 - 633. [Abstract] [Full Text] [PDF]

				J.-M. Bugnicourt, B. Roussel, B. Tramier, C. Lamy, and O. Godefroy Cerebral venous thrombosis and plasma concentrations of factor VIII and von Willebrand factor: a case control study J. Neurol. Neurosurg. Psychiatry, July 1, 2007; 78(7): 699 - 701. [Abstract] [Full Text] [PDF]

				C. J. Glueck, K. Golnik, and Ping Wang Amaurosis Fugax Caused by Heritable Thrombophilia-Hypofibrinolysis in Cases Without Carotid Atherosclerosis: Thromboprophylaxis Prevents Subsequent Transient Monocular Partial Blindness Clinical and Applied Thrombosis/Hemostasis, April 1, 2007; 13(2): 124 - 129. [Abstract] [PDF]

				M. Girot, J. M. Ferro, P. Canhao, J. Stam, M.-G. Bousser, F. Barinagarrementeria, D. Leys, and for the ISCVT Investigators Predictors of Outcome in Patients With Cerebral Venous Thrombosis and Intracerebral Hemorrhage Stroke, February 1, 2007; 38(2): 337 - 342. [Abstract] [Full Text] [PDF]

				I. Gosk-Bierska, W. Wysokinski, R. D. Brown Jr, K. Karnicki, D. Grill, H. Wiste, E. Wysokinska, and R. D. McBane II Cerebral venous sinus thrombosis: Incidence of venous thrombosis recurrence and survival. Neurology, September 12, 2006; 67(5): 814 - 819. [Abstract] [Full Text] [PDF]

				F. Dentali, M. Gianni, M. A. Crowther, and W. Ageno Natural history of cerebral vein thrombosis: a systematic review Blood, August 15, 2006; 108(4): 1129 - 1134. [Abstract] [Full Text] [PDF]

				S. Cakmak, N. Nighoghossian, V. Desestret, M. Hermier, S. Cartalat-Carel, L. Derex, J. Honnorat, and P. Trouillas Pulmonary embolism: An unusual complication of cerebral venous thrombosis Neurology, October 11, 2005; 65(7): 1136 - 1137. [Full Text] [PDF]

				S Yoshimura, T Ago, T Kitazono, T Yonekura, Y Kumai, J Kuroda, M Kamouchi, H Ooboshi, S Ibayashi, and M Iida Cerebral sinus thrombosis in a patient with Cushing's syndrome J. Neurol. Neurosurg. Psychiatry, August 1, 2005; 76(8): 1182 - 1183. [Full Text] [PDF]

				C. J. Glueck, N. Goldenberg, H. Bell, K. Golnik, and P. Wang Amaurosis Fugax: Associations with Heritable Thrombophilia Clinical and Applied Thrombosis/Hemostasis, July 1, 2005; 11(3): 235 - 241. [Abstract] [PDF]

				G. Sebire, B. Tabarki, D. E. Saunders, I. Leroy, R. Liesner, C. Saint-Martin, B. Husson, A. N. Williams, A. Wade, and F. J. Kirkham Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome Brain, March 1, 2005; 128(3): 477 - 489. [Abstract] [Full Text] [PDF]

				J. M. Ferro, P. Canhao, J. Stam, M.-G. Bousser, F. Barinagarrementeria, and for the ISCVT Investigators Prognosis of Cerebral Vein and Dural Sinus Thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT) Stroke, March 1, 2004; 35(3): 664 - 670. [Abstract] [Full Text] [PDF]